期刊文献+

冠心病患者血浆Chemerin水平变化与颈动脉粥样硬化的关系 被引量:3

Relationship between plasma chemerin and carotid atherosclerosis in cornary disease
下载PDF
导出
摘要 目的探讨Chemerin与冠心病以及Chemerin水平与颈动脉硬化的关系。方法共选入105例冠心病患者及30例正常者,对所有参与者均进行颈动脉彩色多普勒超声检查,测定颈动脉内膜中层厚度(IMT)及斑块性质,并测定Chemerin水平,比较两组之间Chemerin水平及其与IMT的关系。结果冠心病组与正常对照组相比,IMT明显升高[(1.48±0.08)mm:(1.06±0.06)mm,P<0.05],Chemerin水平[(232.25±18.85)pg/L:(196.13±10.58)pg/L,P<0.05]明显升高。Chemerin水平与IMT值呈正相关关系。结论 Chemerin在动脉粥样硬化形成中具有重要作用,且可影响颈动脉结构的变化,导致斑块不稳定。 Objective To investe the relationship between Cornary Disease and the level of Chemerin ,and the relationship be-tween Chemmerin and Carotid Atherosclerosis .Methods Selecting 105 patients with coronary heart disease and 30 normal per-sons .All participants underwent carotid Doppler ultrasound .To measure carotid intima-media thickness (IMT) and plaque na-ture .And determination the leval of Chemerin .Compare the relationship between Chemerin level and IMT of the two groups . Results The IMT value of the Cornary group was siginificantly higher than that of normal group [(1.48 ± 0.08)mm :(1.06 ± 0.06)mm ,P〈0.05] .The level of Chemerin is also have the same correlation [(232.25 ± 18.85)pg/L :(196.13 ± 10.58)pg/L , P〈0.05] .However ,there was a positive correlation between the Chemerin level and IMT .Conclusions Chemerin is closely related to atherosclerosis .And it can affect the structure of carotid ,resulting in the unstable plaque .
出处 《滨州医学院学报》 2014年第2期87-89,共3页 Journal of Binzhou Medical University
基金 国家自然科学基金课题(81200601)
关键词 冠心病 CHEMERIN 颈动脉内膜中层厚度 动脉硬化 Cornary Disease Chemerin Carotid intima-media thickness Atherosclerosis
  • 相关文献

参考文献10

  • 1Bozaoglu K, Bolton K, McMillan J,et al. Chemerin is a novel adi pokine associated with obesity and metabolic syndrome[J]. En- docrinology, 2007,148 (10):4687-4694.
  • 2Rob SG, Song SH, Choi KC,et al. Chemerin-a new adipokine that modulates adipogenesis via its own receptor [J]. Biochem Biophys Res Commun,2007,362(4) :1013-1018.
  • 3杨梅柳,史丽萍.Chemerin与炎症及代谢综合征的研究进展[J].华北煤炭医学院学报,2011,13(5):618-620. 被引量:1
  • 4Parlee SD, Ernst MC, Muruganandan S, et al. Serum Chemerin Levels Vary with Time of Day and Are Modified by Obesity and Tumor Necrosis Factor-a [J]. Endocrinology, 2010, 151 (6) : 2590-2802.
  • 5Wang Z, Nakayama T. Inflammation, a Link between Obesity and Cardiovascular Disease [J]. Mediators of Inflammation, 2010,1155(10):535918.
  • 6Du XY,Zabel BA,Myles T,et al. Regulation of chemerin bioac- tivity by plasma carboxypeptidase N, carboxypeptidase B(activa- ted thrombin- activable fibrinolysis inhibitor), and platelets[J]. J Biol Chem,2009,284(2) : 751-758.
  • 7范书英,于长安,黎娜,郑金刚,彭文华,陈莉,车勇,赵霞,赵桂茹,王丹,王勇.非ST段抬高心肌梗死和不稳定心绞痛患者血浆脂肪激素Chemerin水平及其影响因素研究[J].中国全科医学,2012,15(17):1945-1948. 被引量:18
  • 8Lehrke M,Becker A,Greif M,et al. Chemerin is associated with markers of inflammation and components of the metabolic syn- drome but dose not predict coronary atherosclerosis[J]. Europe- an Journal of Endocrinology, 2009, 16 1(2) : 339- 344.
  • 9范书英,黎娜,于长安,柯元南,郑金刚,彭文华,陈莉,赵霞,赵桂茹,王丹,王勇.冠心病患者血浆Chemerin水平的变化及其影响因素[J].临床心血管病杂志,2012,28(1):31-33. 被引量:14
  • 10Tan KT, Lip GY. Imaging of the unstable plaque[J]. Interna tional Journal of Cardiology,2008,127(2) :157 -165.

二级参考文献30

  • 1WittamerV,Bondue B,Guillabert A,et al.Neutrophil-mediated maturation of chemerin:a link between innate and adaptive immunity[J].Immunol.2005,175(1):487.
  • 2LehrkeM,Becker A,Greif M,et al.Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.Eur[J].Endocrinol.2009,161(2):339.
  • 3DU X Y, ZABEL B A, MYLES T, et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets[J]. J Biol Chem, 2009,284:751--758.
  • 4WITTAMER V, BONDUE B, GUILLABERT A, et al. Neutrophil-mediated maturation of chemerin., a link between innate and adaptive immunity[J]. J Immunol, 2005,175 :487 - 493.
  • 5GUAI.ILLO O, GONZALEZ-JUANATEY J R, LAGO F. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspeetives[J].Trends Cardiovasc Med, 2007, 17:275--283.
  • 6LEHRKE M, BECKER A, GREIF M, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atheroselerosis[J]. Eur J Endocrinol,2009,161: 339 - 344.
  • 7SPIROGLOU S G, KOSTOPOULOS C G, VARA- KIS J N, et al. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis[J].J Atheroscler Thromb, 2010,17: 115--130.
  • 8GORALSKI K B, SINAL C J. Elucidation of chemer in and ehemokine-like receptor-1 function in adipo- cytes by adenoviral mediated shRNA knockdown of gene expression[J].Methods Enzymol, 2009,460 : 289 --312.
  • 9BOZAOGLU K, BOLTON K, MCMILLAN J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome [J].Endocrinology, 2007, 148..4687-4694.
  • 10ERNST M C, SINAI. C J. Chemerin: at the cross roads of inflammation and obesity[J]. Trends Endocrinol Metab,2010,21 ..660-667.

共引文献25

同被引文献28

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部